ICU Medical, Inc.
NASDAQ:ICUIMedical - Instruments & Supplies
+$0.89 today
- Market cap
- $4.46B
- Beta
- 0.78
- P/E (TTM)
- 74.2
- EPS (TTM)
- $1.87
Volume 0.21M
Average 0.29M
ICUI EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
ICU Medical, Inc.NASDAQ: ICUI
EPS (Diluted) · Q2 FY2026 · quarter ended Jun 2026
EPS (Diluted) dips below year-ago levels
Q2 FY2026 EPS (Diluted) of $0.76 fell 46.9% year over year, behind the +177.6% change in trailing-twelve-month EPS (Diluted). Sequentially, it fell 36.7% from the prior quarter.
Context
- EPS (Diluted) increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 6 analysts of $8.93 (+30279.0%) for the fiscal year ending Dec 2026, a step up from the +100.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $0.76-36.7% QoQ
- Last fiscal yearDec 2025
- $0.03+100.6% YoY
- LTMJun 2026
- $1.18+177.6% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 0.03 USD
- Year-over-year change
- +100.6%
- 4-year CAGR
- -71.9%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0.03 | +100.6% |
| FY2024 | 2024-12-31 | (4.83) | -292.7% |
| FY2023 | 2023-12-31 | (1.23) | +60.5% |
| FY2022 | 2022-12-31 | (3.11) | -165.6% |
| FY2021 | 2021-12-31 | 4.74 | — |
EPS (Diluted) vs competitors
How ICUI compares with its peers on the latest reported figures
- ICUI's LTM Jun 2026 EPS (Diluted) of $1.18 is the 2nd highest of the 5 companies compared; the peer median is -$1.04.
- Its year-over-year change of +177.6% is the highest of 5, against a peer median of -304.4%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $4.14 | -29.0% | -6.1% | |
| LTM Jun 2026 | $1.18 | +177.6% | — | |
| LTM Mar 2026 | -$0.05 | +59.1% | — | |
| LTM Jun 2026 | -$2.04 | -579.8% | — | |
| LTM Jun 2026 | -$23.29 | -648.0% | — | |
| Peer median (excluding ICUI) | -$1.04 | -304.4% | -6.1% | |
Competitors are the stored peer set for ICUI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.32B | 2.28B | 2.26B | 2.38B | 2.23B |
| Cost of Revenue | 824.82M | 1.58B | 1.52B | 1.56B | 1.41B |
| Gross Profit | 491.49M | 697.76M | 739.87M | 824.78M | 819.66M |
| Gross Margin | 37.3% | 30.6% | 32.8% | 34.6% | 36.8% |
| Research & Development | 47.5M | 92.98M | 85.34M | 88.62M | 87.5M |
| Selling, General & Admin | 302.58M | 608.35M | 606.69M | 638.76M | 625.21M |
| Operating Expenses | 368.25M | 740.66M | 717.05M | 781.82M | 712.71M |
| Depreciation & Amortization | 89.7M | 235.15M | 228.77M | 219.51M | 200.74M |
| EBITDA | 213.86M | 191.55M | 253.2M | 260.04M | 309.29M |
| EBITDA Margin | 16.2% | 8.4% | 11.2% | 10.9% | 13.9% |
| Operating Income | 123.25M | (42.9M) | 22.83M | 42.96M | 106.95M |
| Operating Margin | 9.4% | -1.9% | 1.0% | 1.8% | 4.8% |
| Interest Income | 2.84M | 4.43M | 7.51M | 10.79M | 10.31M |
| Interest Expense | 858K | 70.81M | 102.73M | 106.54M | 105.38M |
| Other Income / Expenses | (59K) | (71.51M) | (101.12M) | (108.98M) | (103.78M) |
| Income Before Tax | 123.19M | (114.41M) | (78.3M) | (66.01M) | 3.17M |
| Pre-Tax Margin | 9.4% | -5.0% | -3.5% | -2.8% | 0.1% |
| Income Tax Expense | 20.05M | (40.12M) | (48.64M) | 51.68M | 2.44M |
| Net Income | 103.14M | (74.29M) | (29.66M) | (117.69M) | 732K |
| Net Margin | 7.8% | -3.3% | -1.3% | -4.9% | 0.0% |
| EPS (Basic) | 4.86 | (3.11) | (1.23) | (4.83) | 0.03 |
| EPS (Diluted) | 4.74 | (3.11) | (1.23) | (4.83) | 0.03 |
| Weighted Avg Shares | 21.21M | 23.87M | 24.09M | 24.39M | 24.64M |
| Weighted Avg Shares (Diluted) | 21.78M | 23.87M | 24.09M | 24.39M | 24.9M |
ICU Medical, Inc.
NASDAQ:ICUI
Intrinsic Alpha fair value
Locked
Current Price
$178.48
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.